Pharmaron Beijing Co., Ltd. (300759.SZ) Issues Profit Warning, Forecasts 2025 Net Profit Attributable to Shareholders of 1.614-1.686 Billion Yuan, Down 6%-10%

Stock News01-13

Pharmaron Beijing Co., Ltd. (300759.SZ) has released its annual performance forecast for 2025, anticipating a net profit attributable to the shareholders of the listed company in the range of 1.614 billion to 1.686 billion yuan, representing a year-on-year decrease of 6% to 10%.

According to the company's preliminary calculations, non-recurring gains and losses attributable to shareholders for the 2025 fiscal year are estimated to be approximately 110 million to 130 million yuan, primarily comprising government grants recognized in current profit or loss, fair value change gains from other non-current financial assets, and gains or losses related to investments in low-to-medium risk bank wealth management products.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1158425554?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-13 18:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1158425554","market":"fut","top_or_hot":-1,"title":"Pharmaron Beijing Co., Ltd. (300759.SZ) Issues Profit Warning, Forecasts 2025 Net Profit Attributable to Shareholders of 1.614-1.686 Billion Yuan, Down 6%-10%","media":"Stock News","content":"<p>Pharmaron Beijing Co., Ltd. (300759.SZ) has released its annual performance forecast for 2025, anticipating a net profit attributable to the shareholders of the listed company in the range of 1.614 billion to 1.686 billion yuan, representing a year-on-year decrease of 6% to 10%.</p>\n<p>According to the company's preliminary calculations, non-recurring gains and losses attributable to shareholders for the 2025 fiscal year are estimated to be approximately 110 million to 130 million yuan, primarily comprising government grants recognized in current profit or loss, fair value change gains from other non-current financial assets, and gains or losses related to investments in low-to-medium risk bank wealth management products.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pharmaron Beijing Co., Ltd. (300759.SZ) Issues Profit Warning, Forecasts 2025 Net Profit Attributable to Shareholders of 1.614-1.686 Billion Yuan, Down 6%-10%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharmaron Beijing Co., Ltd. (300759.SZ) Issues Profit Warning, Forecasts 2025 Net Profit Attributable to Shareholders of 1.614-1.686 Billion Yuan, Down 6%-10%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-01-13 18:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pharmaron Beijing Co., Ltd. (300759.SZ) has released its annual performance forecast for 2025, anticipating a net profit attributable to the shareholders of the listed company in the range of 1.614 billion to 1.686 billion yuan, representing a year-on-year decrease of 6% to 10%.</p>\n<p>According to the company's preliminary calculations, non-recurring gains and losses attributable to shareholders for the 2025 fiscal year are estimated to be approximately 110 million to 130 million yuan, primarily comprising government grants recognized in current profit or loss, fair value change gains from other non-current financial assets, and gains or losses related to investments in low-to-medium risk bank wealth management products.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03759","symbol_name":"康龙化成","start_time":0,"source_url":"","article_id":"1158425554","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1158425554","pubTimestamp":1768301899,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Pharmaron Beijing Co., Ltd. (300759.SZ) has released its annual performance forecast for 2025, anticipating a net profit attributable to the shareholders of the listed company in the range of 1.614...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300759":"康龙化成","03759":"康龙化成","BK1141":"生命科学工具和服务","BK1576":"医药外包概念","BK0216":"研究试验"},"translate_title":"康龙化成北京股份有限公司（300759.SZ）发布盈利预警，预计2025年归属股东净利润16.14-16.86亿元，下降6%-10%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300759":1,"03759":1},"content_text":"Pharmaron Beijing Co., Ltd. (300759.SZ) has released its annual performance forecast for 2025, anticipating a net profit attributable to the shareholders of the listed company in the range of 1.614 billion to 1.686 billion yuan, representing a year-on-year decrease of 6% to 10%.\nAccording to the company's preliminary calculations, non-recurring gains and losses attributable to shareholders for the 2025 fiscal year are estimated to be approximately 110 million to 130 million yuan, primarily comprising government grants recognized in current profit or loss, fair value change gains from other non-current financial assets, and gains or losses related to investments in low-to-medium risk bank wealth management products.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1158425554","isCrawlerRequest":true}